A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy
Clinical trial NCT03796962 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03796962
- Sponsor
- Xenon Pharmaceuticals Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-30
- Primary completion
- 2021-09-02
- Enrollment
- 325
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.